1 Causes and pathophysiology

Myocardial infarction results from a sudden interruption of blood supply to the heart muscle, most often in a coronary artery. The resulting ischemia deprives tissue of oxygen and nutrients, leading first to reversible injury and then to cell death if flow is not restored quickly. The extent of injury depends on the size of the vessel involved, the duration of occlusion, and the amount of existing collateral circulation.

1.1 Coronary artery disease

In many cases, myocardial infarction develops on the background of coronary artery disease. Over time, fatty deposits and fibrous tissue narrow the coronary arteries, reducing the reserve available to meet increased cardiac demand. Even before a complete blockage occurs, these plaques can impair blood flow and create vulnerable areas within the vessel wall.

1.2 Plaque rupture and thrombosis

A common immediate event is rupture or erosion of an atherosclerotic plaque. When the plaque surface is disrupted, blood components such as platelets and clotting factors rapidly accumulate at the site, forming a thrombus. The clot may partially or completely obstruct the artery, abruptly cutting off perfusion to downstream myocardium.

1.3 Oxygen supply-demand mismatch

Some infarctions arise when the heart’s oxygen demand exceeds the available supply without an acute plaque rupture. This imbalance may occur during severe anemia, marked tachycardia, low blood pressure, or respiratory illness. In such settings, the myocardium becomes ischemic because the circulation cannot deliver enough oxygen for the level of work being performed.

1.4 Types of myocardial infarction

Myocardial infarction is classified according to the electrocardiographic pattern and underlying mechanism. These categories help guide urgent treatment and clarify the likely cause of injury. Although the terminology varies, the central feature is still necrosis of heart muscle due to inadequate blood flow.

1.4.1 ST-elevation myocardial infarction

ST-elevation myocardial infarction is typically associated with a sudden, complete coronary artery occlusion. It is identified on electrocardiography by characteristic ST-segment elevation in contiguous leads. Because the affected artery is usually fully blocked, rapid reperfusion is especially important.

1.4.2 Non-ST-elevation myocardial infarction

Non-ST-elevation myocardial infarction generally reflects a partial or intermittent obstruction. The electrocardiogram may show ST-segment depression, T-wave inversion, or no clear acute ST elevation. Cardiac biomarkers are elevated, confirming injury to the myocardium.

1.4.3 Type 2 myocardial infarction

Type 2 myocardial infarction occurs when there is a mismatch between oxygen supply and demand rather than a primary coronary thrombus. It is often associated with other illnesses that strain the heart or limit oxygen delivery. Management focuses on correcting the underlying cause as well as supporting cardiac function.

2 Risk factors

Risk factors for myocardial infarction include both modifiable exposures and fixed patient characteristics. Their effects often combine, increasing the likelihood of atherosclerosis and acute coronary events. Recognition of these factors is important for prevention and long-term care.

2.1 Modifiable risk factors

Several major risks can be reduced through medical treatment or changes in daily habits. These factors are closely linked to the development and progression of coronary artery disease. Addressing them lowers the chance of first and recurrent infarction.

2.1.1 Smoking

Tobacco use damages the vascular lining, promotes inflammation, and increases clot formation. It also reduces oxygen delivery by increasing carbon monoxide exposure and impairing lung function. The risk declines after cessation, though it may remain elevated for some time.

2.1.2 Hypertension

High blood pressure increases mechanical stress on arterial walls and accelerates atherosclerosis. It also raises the workload of the left ventricle, increasing oxygen demand. Persistent elevation of pressure is a major contributor to coronary events.

2.1.3 Dyslipidemia

Abnormal lipid levels, particularly elevated low-density lipoprotein cholesterol, promote plaque formation in the coronary arteries. Over time, these deposits can become unstable and prone to rupture. Lowering harmful lipid fractions reduces cardiovascular risk.

2.1.4 Diabetes mellitus

Diabetes is associated with endothelial dysfunction, accelerated atherosclerosis, and impaired healing of blood vessels. Elevated glucose levels also worsen inflammation and thrombosis. People with diabetes may develop more diffuse and severe coronary disease.

2.2 Non-modifiable risk factors

Some determinants of risk cannot be changed, but they help identify individuals who may benefit from closer monitoring. These factors influence susceptibility to coronary disease and myocardial infarction across the life span. They are often considered alongside lifestyle and metabolic risks.

2.2.1 Age

The likelihood of myocardial infarction rises with age as arteries accumulate structural damage and atherosclerotic plaque. Older adults are also more likely to have multiple coexisting illnesses. These changes increase both baseline risk and complication rates.

2.2.2 Sex

Sex influences the pattern of coronary disease and the age at which it appears. Men tend to develop infarction earlier in life, while risk in women rises substantially after midlife. Clinical presentation may also differ between sexes.

2.2.3 Family history

A family history of premature coronary disease suggests inherited susceptibility, shared metabolic traits, or both. Such backgrounds can indicate a higher likelihood of early atherosclerosis. The presence of affected close relatives is often used in risk assessment.

2.3 Other contributing conditions

Additional medical problems may contribute to infarction by raising cardiac workload or reducing oxygen delivery. These include chronic kidney disease, inflammatory disorders, and certain rhythm disturbances. Acute stressors such as severe infection or hemorrhage can also precipitate ischemia in vulnerable individuals.

3 Clinical presentation

The symptoms of myocardial infarction vary from classic severe chest pain to subtle or absent complaints. Presentation depends on the extent of injury, the vessel involved, the patient’s age, and the presence of diabetes or other conditions. Because delays in treatment can worsen outcomes, early recognition is critical.

3.1 Chest pain and discomfort

Chest discomfort is the most recognized symptom and is often described as pressure, tightness, heaviness, or squeezing. It may last longer than typical angina and may not improve with rest. Some patients feel pain in the center or left side of the chest, while others report a vague sense of distress.

3.2 Associated symptoms

Myocardial infarction commonly causes symptoms beyond the chest, reflecting autonomic activation and reduced cardiac output. These features can help distinguish it from less serious causes of discomfort. Their intensity and combination vary widely.

3.2.1 Dyspnea

Shortness of breath may occur because the heart is pumping inefficiently or because lung congestion develops. It can appear with exertion or at rest and may be the dominant complaint. In some patients, dyspnea replaces chest pain as the main warning sign.

3.2.2 Diaphoresis

Profuse sweating is a frequent accompaniment of acute coronary ischemia. It reflects sympathetic nervous system activation during severe pain or physiologic stress. The skin may feel cold and clammy during the episode.

3.2.3 Nausea and vomiting

Gastrointestinal symptoms can accompany infarction, especially when the inferior wall of the heart is involved. Nausea may occur with abdominal discomfort or a sense of indigestion. These complaints can mislead patients into thinking the problem is digestive rather than cardiac.

3.2.4 Syncope

Fainting may result from dangerous arrhythmias, marked hypotension, or profound reduction in cardiac output. It is less common than chest pain but often signals a serious event. Syncope in the setting of possible ischemia warrants urgent evaluation.

3.3 Atypical and silent presentations

Some infarctions present without classic chest pain, particularly in older adults, women, and people with diabetes. Symptoms may include fatigue, weakness, confusion, or isolated shortness of breath. Silent infarction may be discovered only through testing performed for another reason.

4 Diagnosis

Diagnosis relies on a combination of clinical assessment, electrocardiography, blood tests, and imaging. No single finding is sufficient in every case, so clinicians interpret results in context. Rapid diagnosis is essential because treatment is time-sensitive.

4.1 Medical history and physical examination

History taking focuses on the character, duration, and triggers of pain or discomfort, as well as associated symptoms. Physical examination may reveal pallor, sweating, abnormal heart sounds, lung crackles, or signs of shock. Findings can suggest the severity of injury but may be normal early in the course.

4.2 Electrocardiography

Electrocardiography is a frontline diagnostic tool because it is quick, noninvasive, and informative. It can show patterns consistent with acute ischemia, prior injury, or other conditions. Serial recordings are often useful when initial findings are inconclusive.

4.2.1 ST-segment changes

ST-segment elevation or depression may indicate acute ischemia or infarction. The distribution of changes across leads can help localize the affected region of the heart. Dynamic changes on repeat tracings strengthen the diagnosis.

4.2.2 T-wave abnormalities

T-wave inversion or flattening may accompany ischemia, especially in non-ST-elevation events. These changes are not specific on their own, but they support the clinical picture. Evolution over time can provide additional diagnostic clues.

4.2.3 Pathological Q waves

Pathological Q waves may develop after transmural injury and can suggest completed infarction. They are more often associated with established damage than with very early presentation. Their appearance helps document the extent and location of prior myocardial necrosis.

4.3 Cardiac biomarkers

Blood tests measure substances released when heart muscle cells are injured. Elevated biomarkers confirm myocardial damage, although the exact cause must still be determined clinically. Serial measurements are commonly used to detect rising or falling levels.

4.3.1 Troponin testing

Troponin is the most sensitive and specific commonly used biomarker for myocardial injury. Levels rise after cell death and remain elevated for a period of time. A characteristic increase and subsequent decrease support the diagnosis of acute infarction.

4.3.2 Creatine kinase-MB

Creatine kinase-MB is another marker that may rise after myocardial injury. It is less specific than troponin but can still be helpful in selected cases. Because it returns to normal more quickly, it may assist in detecting reinfarction.

4.4 Imaging studies

Imaging helps assess wall motion, identify complications, and evaluate the coronary arteries. The choice of test depends on stability, availability, and the clinical question. Some studies are used during the acute event, while others assist in follow-up.

4.4.1 Echocardiography

Echocardiography can show regional wall-motion abnormalities and overall pumping performance. It is useful for identifying impaired ventricular function and mechanical complications. The test is noninvasive and can be performed at the bedside.

4.4.2 Coronary angiography

Coronary angiography visualizes the coronary arteries directly and can identify the site of obstruction. It is central to decisions about revascularization. In many cases, the procedure can be followed immediately by intervention.

4.4.3 Cardiac MRI

Cardiac magnetic resonance imaging provides detailed information about tissue injury, scar, and viability. It can distinguish infarction from other causes of myocardial dysfunction. This modality is especially helpful when the diagnosis remains uncertain.

4.5 Differential diagnosis

Several other disorders can mimic myocardial infarction, including angina, aortic dissection, pulmonary embolism, pericarditis, and gastrointestinal disease. Some noncardiac conditions cause chest discomfort that is similar in location or quality. Careful evaluation is needed to avoid missing either an infarction or another urgent illness.

5 Management

Management of myocardial infarction aims to restore blood flow, limit myocardial injury, relieve symptoms, and prevent complications. Treatment begins as soon as the diagnosis is suspected. The urgency of care reflects the progressive nature of tissue damage.

5.1 Immediate emergency treatment

Initial therapy is directed at stabilizing the patient and reducing clot growth. This phase often begins before definitive imaging or laboratory confirmation is complete. Early treatment can improve survival and preserve heart function.

5.1.1 Oxygen therapy

Oxygen is given when blood oxygen levels are low or when respiratory distress is present. Routine use in all patients is less helpful than targeted administration. The main goal is to correct hypoxemia without unnecessary treatment.

5.1.2 Antiplatelet therapy

Antiplatelet drugs reduce platelet aggregation at the site of coronary thrombosis. They are a core part of early treatment because clot expansion can worsen ischemia. In many protocols, therapy is started promptly after suspicion of infarction.

5.1.3 Anticoagulation

Anticoagulant medications limit further clot formation by interfering with the coagulation cascade. They are often used alongside antiplatelet agents in acute care. Their use requires attention to bleeding risk and clinical context.

5.1.4 Pain relief

Analgesia helps reduce distress and sympathetic stimulation during an infarction. Relief of pain can also improve cooperation with other treatments. Pain control is balanced against the need to monitor symptoms and avoid side effects.

5.2 Reperfusion therapy

Reperfusion is the restoration of blood flow to the affected myocardium. It is the most effective way to reduce irreversible damage when implemented early. The method chosen depends on the type of infarction, timing, and local resources.

5.2.1 Percutaneous coronary intervention

Percutaneous coronary intervention opens the blocked artery mechanically, usually with balloon dilation and stent placement. It is a preferred strategy when it can be performed rapidly by an experienced team. Successful intervention can restore perfusion and improve outcomes.

5.2.2 Thrombolytic therapy

Thrombolytic drugs dissolve clots and can be used when immediate mechanical reperfusion is not available. They are most beneficial when given early in the course of ST-elevation infarction. Because they increase bleeding risk, patient selection is important.

5.3 Supportive and adjunctive care

Additional medications and monitoring help reduce stress on the heart and improve recovery. These treatments are often started during the acute hospitalization and continued afterward. Their benefits extend beyond the immediate event.

5.3.1 Beta blockers

Beta blockers reduce heart rate, contractility, and oxygen demand. They may also lower the risk of some arrhythmias. Use depends on hemodynamic stability and the absence of contraindications.

5.3.2 Statins

Statins lower cholesterol and have anti-inflammatory effects on atherosclerotic plaque. They are used after infarction to reduce future cardiovascular events. Their long-term role is central to secondary prevention.

5.3.3 ACE inhibitors

Angiotensin-converting enzyme inhibitors help limit adverse remodeling of the heart after injury. They can improve outcomes in selected patients, especially when ventricular function is reduced. Blood pressure, kidney function, and potassium levels are monitored during treatment.

5.4 Complication management

Complications are treated according to their type and severity. This may require rhythm control, support for low blood pressure, treatment of heart failure, or urgent surgical intervention. Close surveillance in the early period is essential.

6 Complications

Myocardial infarction can cause immediate and delayed complications involving rhythm, pumping ability, and structural integrity. Some are life-threatening and require urgent intervention. The risk depends in part on infarct size and location.

6.1 Arrhythmias

Abnormal heart rhythms are common after infarction because injured tissue disrupts electrical conduction. These may include tachyarrhythmias, bradyarrhythmias, and conduction blocks. Some are transient, while others can rapidly become fatal.

6.2 Heart failure

Loss of contracting myocardium can impair the heart’s ability to pump blood effectively. Symptoms may include shortness of breath, fluid retention, and fatigue. Severe dysfunction may progress to pulmonary edema or circulatory collapse.

6.3 Cardiogenic shock

Cardiogenic shock is a state of profound circulatory failure caused by inadequate cardiac output. It is a medical emergency associated with high mortality. Rapid recognition and treatment are necessary to support organ perfusion.

6.4 Mechanical complications

Infarction can weaken the heart wall or supporting structures enough to cause tearing or rupture. These events are uncommon but highly dangerous. They often occur after large transmural infarcts.

6.4.1 Papillary muscle rupture

Rupture of a papillary muscle can lead to sudden severe mitral valve regurgitation. This causes acute pulmonary congestion and hemodynamic instability. It is a surgical emergency.

6.4.2 Ventricular septal rupture

A tear in the septum between the ventricles creates an abnormal shunt. This can produce a new murmur and rapid clinical deterioration. The condition usually requires urgent repair.

6.4.3 Free wall rupture

Rupture of the ventricular free wall may cause bleeding into the pericardial sac and cardiac tamponade. This often presents abruptly and is frequently fatal without immediate intervention. It is among the most severe complications of infarction.

6.5 Pericarditis

Inflammation of the pericardium may occur after myocardial injury. It can cause pleuritic chest pain and a friction rub on examination. In some cases, it develops early; in others, it appears later as part of postinfarction inflammation.

7 Prognosis

Outcome after myocardial infarction varies widely according to the amount of myocardium affected, the speed of treatment, and the presence of complications. Modern care has improved survival, but risk remains significant, especially in large infarctions or in unstable patients. Recovery may include both physical and emotional adjustment.

7.1 Short-term outcomes

The earliest period after infarction carries the highest risk of death and serious complications. Prognosis is influenced by heart rhythm, blood pressure, extent of injury, and treatment delays. Patients who receive prompt reperfusion and remain hemodynamically stable generally fare better.

7.2 Long-term survival

Long-term survival depends on residual heart function, the burden of coronary disease, and adherence to preventive therapy. Recurrent infarction and chronic heart failure are important causes of later morbidity. Consistent follow-up and risk reduction improve outlook.

7.3 Prognostic scoring systems

Clinical scoring systems combine variables such as age, vital signs, biomarker levels, and electrocardiographic findings. These tools help estimate risk and guide management intensity. They are most useful when integrated with bedside judgment rather than used alone.

8 Prevention

Prevention focuses on reducing atherosclerotic risk and avoiding recurrent events after an infarction. Effective prevention often requires sustained lifestyle and medical measures. Public health approaches and individualized care both play important roles.

8.1 Lifestyle modification

Dietary improvement, regular physical activity, weight management, and avoidance of tobacco can lower cardiovascular risk. These measures support blood pressure, glucose, and lipid control. Their benefits increase when maintained over time.

8.2 Control of risk factors

Treatment of hypertension, diabetes, and dyslipidemia reduces the likelihood of coronary events. Regular monitoring allows therapy to be adjusted as health status changes. Preventive care often involves a combination of medication and behavioral change.

8.3 Secondary prevention after infarction

After myocardial infarction, long-term prevention aims to reduce recurrence and improve quality of life. This includes medicines, rehabilitation, and follow-up visits. The period after discharge is especially important for establishing durable habits.

8.3.1 Medication adherence

Taking prescribed medications consistently lowers the risk of recurrent ischemia and complications. Common therapies may include antiplatelet agents, statins, beta blockers, and other cardioprotective drugs. Missed doses can reduce the benefit of treatment.

8.3.2 Cardiac rehabilitation

Cardiac rehabilitation combines supervised exercise, education, and risk-factor counseling. It helps patients regain confidence and improve functional capacity. Participation is associated with better adherence and healthier long-term behavior.

9 Epidemiology

Myocardial infarction is a major cause of illness and death worldwide. Its frequency reflects the prevalence of coronary risk factors, access to acute care, and population age structure. Patterns differ across countries and over time.

9.1 Global burden

The condition contributes substantially to emergency admissions and cardiovascular mortality. Although treatment has improved survival in many settings, the overall burden remains high because of aging populations and widespread risk factors. The impact extends to disability, healthcare use, and productivity loss.

9.2 Age and sex distribution

Incidence increases with advancing age, and most events occur in middle-aged and older adults. Men are affected earlier on average, while the gap narrows with age. Differences in symptom presentation and diagnosis can influence reported rates.

Over recent decades, mortality from myocardial infarction has declined in many regions due to prevention and improved treatment. At the same time, changes in lifestyle and longevity have altered the underlying population risk. The balance of these forces varies by healthcare system and demographic pattern.

10 History

The understanding of myocardial infarction has developed gradually through clinical observation, pathological study, and technological progress. Early descriptions were limited by the inability to visualize coronary disease directly. Later advances transformed both diagnosis and survival.

10.1 Early descriptions

Before modern cardiology, sudden chest pain and death were often recognized without a clear explanation. Autopsy studies eventually linked these events to coronary blockage and heart muscle damage. This connection established the basis for the modern concept of infarction.

10.2 Advances in diagnosis and treatment

The introduction of electrocardiography, enzyme testing, and coronary imaging improved diagnostic accuracy. These tools allowed clinicians to identify infarction more reliably during life rather than only after death. Treatment also evolved from rest and symptom relief to active intervention.

10.3 Development of reperfusion therapy

Reperfusion therapy marked a major turning point in care. Thrombolytic drugs and later percutaneous coronary intervention made it possible to reopen blocked arteries quickly. These approaches reduced mortality and became central to emergency management.